Status:
UNKNOWN
Clinical-immunological Features of DNER Ataxia
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
DNER Ataxia
Eligibility:
All Genders
18+ years
Brief Summary
Using a retrospective cohort of 34 patients with DNER ataxia, we will characterize clinical presentation, tumor associations, and outcomes.
Eligibility Criteria
Inclusion
- Patient \> 18 years old
- Patient with neurological disorder
- Patient with DNER antibodies in sera or CSF
Exclusion
- \- No available clinical data
- Patient without DNER antibodies or neurological disorder
Key Trial Info
Start Date :
June 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05225896
Start Date
June 15 2021
End Date
June 1 2022
Last Update
February 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HCL Hôpital Neurologique / Groupement EST
Bron, France